Christine Gustafson shares her story of living with Thyroid Eye Disease, where access to care and understanding often discriminates.

Individuals with autoimmune diseases affecting the thyroid can suffer eye complications in the form of Graves’ orbitopathy, in which inflammation in and around the orbit leads to eyelid retraction, ...

Thyroid Eye Disease (TED) is increasingly affecting women over 40, causing bulging eyes and potentially leading to sight loss ...

University of Miami Miller School of Medicine researchers have identified molecular evidence linking human papillomavirus ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teprotumumab (Tepezza), the first medicine licensed ...

A recent study from Bascom Palmer Eye Institute uncovered potential molecular evidence linking human papillomavirus (HPV) to ...

The U.K. drug regulator on Wednesday approved Amgen’s (NASDAQ:AMGN) intravenous medication teprotumumab (Tepezza) as the ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Thyroid Eye Disease Treatment ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Tepezza (teprotumumab (Tepezza). This ...

In the weeks to come, the European Commission will issue a decision on the first severe thyroid eye disease treatment.

Thyroid eye disease, also known as Graves orbitopathy ... This condition results from an autoimmune attack on the soft tissues around and behind the eyes. It activates the insulin-like growth ...

as the country’s medicine indicated specifically for adults with moderate to severe thyroid eye disease (TED). The decision from the U.K.'s Medicines and Healthcare Products Regulatory Agency ...